Acute kidney injury in patients with cirrhosis : Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting
Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved..
Patients with cirrhosis are prone to developing acute kidney injury (AKI), a complication associated with a markedly increased in-hospital morbidity and mortality, along with a risk of progression to chronic kidney disease. Whereas patients with cirrhosis are at increased risk of developing any phenotype of AKI, hepatorenal syndrome (HRS), a specific form of AKI (HRS-AKI) in patients with advanced cirrhosis and ascites, carries an especially high mortality risk. Early recognition of HRS-AKI is crucial since administration of splanchnic vasoconstrictors may reverse the AKI and serve as a bridge to liver transplantation, the only curative option. In 2023, a joint meeting of the International Club of Ascites (ICA) and the Acute Disease Quality Initiative (ADQI) was convened to develop new diagnostic criteria for HRS-AKI, to provide graded recommendations for the work-up, management and post-discharge follow-up of patients with cirrhosis and AKI, and to highlight priorities for further research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Journal of hepatology - (2024) vom: 26. März |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 25.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1016/j.jhep.2024.03.031 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37017075X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37017075X | ||
| 003 | DE-627 | ||
| 005 | 20240426234011.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jhep.2024.03.031 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1388.xml |
| 035 | |a (DE-627)NLM37017075X | ||
| 035 | |a (NLM)38527522 | ||
| 035 | |a (PII)S0168-8278(24)00214-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Nadim, Mitra K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Acute kidney injury in patients with cirrhosis |b Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 25.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Patients with cirrhosis are prone to developing acute kidney injury (AKI), a complication associated with a markedly increased in-hospital morbidity and mortality, along with a risk of progression to chronic kidney disease. Whereas patients with cirrhosis are at increased risk of developing any phenotype of AKI, hepatorenal syndrome (HRS), a specific form of AKI (HRS-AKI) in patients with advanced cirrhosis and ascites, carries an especially high mortality risk. Early recognition of HRS-AKI is crucial since administration of splanchnic vasoconstrictors may reverse the AKI and serve as a bridge to liver transplantation, the only curative option. In 2023, a joint meeting of the International Club of Ascites (ICA) and the Acute Disease Quality Initiative (ADQI) was convened to develop new diagnostic criteria for HRS-AKI, to provide graded recommendations for the work-up, management and post-discharge follow-up of patients with cirrhosis and AKI, and to highlight priorities for further research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a acute disease quality initiative | |
| 650 | 4 | |a acute kidney injury | |
| 650 | 4 | |a albumin | |
| 650 | 4 | |a ascites | |
| 650 | 4 | |a biomarker | |
| 650 | 4 | |a cirrhosis | |
| 650 | 4 | |a hepatorenal syndrome | |
| 650 | 4 | |a international club of ascites | |
| 650 | 4 | |a liver transplantation | |
| 650 | 4 | |a renal replacement therapy | |
| 650 | 4 | |a terlipressin | |
| 700 | 1 | |a Kellum, John A |e verfasserin |4 aut | |
| 700 | 1 | |a Forni, Lui |e verfasserin |4 aut | |
| 700 | 1 | |a Francoz, Claire |e verfasserin |4 aut | |
| 700 | 1 | |a Asrani, Sumeet K |e verfasserin |4 aut | |
| 700 | 1 | |a Ostermann, Marlies |e verfasserin |4 aut | |
| 700 | 1 | |a Allegretti, Andrew S |e verfasserin |4 aut | |
| 700 | 1 | |a Neyra, Javier A |e verfasserin |4 aut | |
| 700 | 1 | |a Olson, Jody C |e verfasserin |4 aut | |
| 700 | 1 | |a Piano, Salvatore |e verfasserin |4 aut | |
| 700 | 1 | |a VanWagner, Lisa B |e verfasserin |4 aut | |
| 700 | 1 | |a Verna, Elizabeth C |e verfasserin |4 aut | |
| 700 | 1 | |a Akcan-Arikan, Ayse |e verfasserin |4 aut | |
| 700 | 1 | |a Angeli, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Belcher, Justin M |e verfasserin |4 aut | |
| 700 | 1 | |a Biggins, Scott W |e verfasserin |4 aut | |
| 700 | 1 | |a Deep, Akash |e verfasserin |4 aut | |
| 700 | 1 | |a Garcia-Tsao, Guadalupe |e verfasserin |4 aut | |
| 700 | 1 | |a Genyk, Yuri S |e verfasserin |4 aut | |
| 700 | 1 | |a Gines, Pere |e verfasserin |4 aut | |
| 700 | 1 | |a Kamath, Patrick S |e verfasserin |4 aut | |
| 700 | 1 | |a Kane-Gill, Sandra L |e verfasserin |4 aut | |
| 700 | 1 | |a Kaushik, Manish |e verfasserin |4 aut | |
| 700 | 1 | |a Lumlertgul, Nuttha |e verfasserin |4 aut | |
| 700 | 1 | |a Macedo, Etienne |e verfasserin |4 aut | |
| 700 | 1 | |a Maiwall, Rakhi |e verfasserin |4 aut | |
| 700 | 1 | |a Marciano, Sebastian |e verfasserin |4 aut | |
| 700 | 1 | |a Pichler, Raimund H |e verfasserin |4 aut | |
| 700 | 1 | |a Ronco, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Tandon, Puneeta |e verfasserin |4 aut | |
| 700 | 1 | |a Velez, Juan-Carlos Q |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Ravindra L |e verfasserin |4 aut | |
| 700 | 1 | |a Durand, François |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of hepatology |d 1989 |g (2024) vom: 26. März |w (DE-627)NLM012604372 |x 1600-0641 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:26 |g month:03 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jhep.2024.03.031 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 26 |c 03 | ||